ITCI
Ensign Peak Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,562
| Closed | -$2.47M | – | 1737 |
|
|
2024
Q4 | $2.47M | Buy |
29,562
+1,298
| +5% | +$108K | ﹤0.01% | 849 |
|
|
2024
Q3 | $2.07M | Sell |
28,264
-13,373
| -32% | -$979K | ﹤0.01% | 931 |
|
|
2024
Q2 | $2.85M | Sell |
41,637
-100,000
| -71% | -$6.85M | 0.01% | 784 |
|
|
2024
Q1 | $9.8M | Buy |
141,637
+98,574
| +229% | +$6.82M | 0.02% | 456 |
|
|
2023
Q4 | $3.08M | Hold |
43,063
| – | – | 0.01% | 754 |
|
|
2023
Q3 | $2.24M | Sell |
43,063
-825
| -2% | -$43K | ﹤0.01% | 800 |
|
|
2023
Q2 | $2.78M | Hold |
43,888
| – | – | 0.01% | 762 |
|
|
2023
Q1 | $2.38M | Buy |
43,888
+16,948
| +63% | +$918K | 0.01% | 781 |
|
|
2022
Q4 | $1.43M | Buy |
26,940
+2,600
| +11% | +$138K | ﹤0.01% | 942 |
|
|
2022
Q3 | $1.13M | Sell |
24,340
-101,153
| -81% | -$4.71M | ﹤0.01% | 1005 |
|
|
2022
Q2 | $7.16M | Sell |
125,493
-9,060
| -7% | -$517K | 0.02% | 438 |
|
|
2022
Q1 | $8.23M | Buy |
134,553
+11,226
| +9% | +$687K | 0.02% | 470 |
|
|
2021
Q4 | $6.46M | Buy |
123,327
+39,067
| +46% | +$2.04M | 0.01% | 592 |
|
|
2021
Q3 | $3.14M | Buy |
84,260
+12,463
| +17% | +$465K | 0.01% | 859 |
|
|
2021
Q2 | $2.93M | Hold |
71,797
| – | – | 0.01% | 899 |
|
|
2021
Q1 | $2.44M | Hold |
71,797
| – | – | 0.01% | 1010 |
|
|
2020
Q4 | $2.28M | Buy |
71,797
+43,806
| +157% | +$1.39M | 0.01% | 985 |
|
|
2020
Q3 | $718K | Buy |
+27,991
| New | +$718K | ﹤0.01% | 1435 |
|